rs2272901

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000451095.5(ENSG00000228408):​n.174G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.25 in 395,378 control chromosomes in the GnomAD database, including 13,419 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.22 ( 4232 hom., cov: 32)
Exomes 𝑓: 0.27 ( 9187 hom. )

Consequence

ENSG00000228408
ENST00000451095.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.785

Publications

6 publications found
Variant links:
Genes affected
TAB2 (HGNC:17075): (TGF-beta activated kinase 1 (MAP3K7) binding protein 2) The protein encoded by this gene is an activator of MAP3K7/TAK1, which is required for for the IL-1 induced activation of nuclear factor kappaB and MAPK8/JNK. This protein forms a kinase complex with TRAF6, MAP3K7 and TAB1, and it thus serves as an adaptor that links MAP3K7 and TRAF6. This protein, along with TAB1 and MAP3K7, also participates in the signal transduction induced by TNFSF11/RANKl through the activation of the receptor activator of NF-kappaB (TNFRSF11A/RANK), which may regulate the development and function of osteoclasts. Studies of the related mouse protein indicate that it functions to protect against liver damage caused by chemical stressors. Mutations in this gene cause congenital heart defects, multiple types, 2 (CHTD2). Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
TAB2 Gene-Disease associations (from GenCC):
  • chromosome 6q24-q25 deletion syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • congenital heart defects, multiple types, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
  • polyvalvular heart disease syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.39 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000451095.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TAB2
NR_125861.2
n.174G>A
non_coding_transcript_exon
Exon 2 of 3
TAB2
NM_001292035.3
c.-134G>A
5_prime_UTR
Exon 2 of 7NP_001278964.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000228408
ENST00000451095.5
TSL:1
n.174G>A
non_coding_transcript_exon
Exon 2 of 3
ENSG00000228408
ENST00000443992.1
TSL:2
n.99G>A
non_coding_transcript_exon
Exon 2 of 3
ENSG00000228408
ENST00000635954.1
TSL:5
n.164G>A
non_coding_transcript_exon
Exon 2 of 4

Frequencies

GnomAD3 genomes
AF:
0.224
AC:
34001
AN:
152046
Hom.:
4235
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.127
Gnomad AMI
AF:
0.332
Gnomad AMR
AF:
0.197
Gnomad ASJ
AF:
0.355
Gnomad EAS
AF:
0.406
Gnomad SAS
AF:
0.282
Gnomad FIN
AF:
0.172
Gnomad MID
AF:
0.297
Gnomad NFE
AF:
0.270
Gnomad OTH
AF:
0.240
GnomAD4 exome
AF:
0.266
AC:
64732
AN:
243214
Hom.:
9187
Cov.:
0
AF XY:
0.270
AC XY:
37125
AN XY:
137332
show subpopulations
African (AFR)
AF:
0.126
AC:
894
AN:
7068
American (AMR)
AF:
0.166
AC:
3593
AN:
21584
Ashkenazi Jewish (ASJ)
AF:
0.357
AC:
2541
AN:
7124
East Asian (EAS)
AF:
0.415
AC:
3593
AN:
8656
South Asian (SAS)
AF:
0.288
AC:
14147
AN:
49042
European-Finnish (FIN)
AF:
0.191
AC:
1855
AN:
9712
Middle Eastern (MID)
AF:
0.284
AC:
705
AN:
2486
European-Non Finnish (NFE)
AF:
0.272
AC:
34344
AN:
126058
Other (OTH)
AF:
0.266
AC:
3060
AN:
11484
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
2142
4284
6427
8569
10711
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
274
548
822
1096
1370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.223
AC:
33994
AN:
152164
Hom.:
4232
Cov.:
32
AF XY:
0.221
AC XY:
16428
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.126
AC:
5247
AN:
41512
American (AMR)
AF:
0.197
AC:
3011
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.355
AC:
1231
AN:
3470
East Asian (EAS)
AF:
0.405
AC:
2089
AN:
5160
South Asian (SAS)
AF:
0.283
AC:
1362
AN:
4820
European-Finnish (FIN)
AF:
0.172
AC:
1826
AN:
10592
Middle Eastern (MID)
AF:
0.296
AC:
87
AN:
294
European-Non Finnish (NFE)
AF:
0.270
AC:
18334
AN:
67998
Other (OTH)
AF:
0.239
AC:
504
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1358
2716
4075
5433
6791
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
376
752
1128
1504
1880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.261
Hom.:
8463
Bravo
AF:
0.221
Asia WGS
AF:
0.290
AC:
1005
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
4.4
DANN
Benign
0.57
PhyloP100
0.79
PromoterAI
-0.026
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2272901; hg19: chr6-149539773; API